Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

What's New > Guideline Archive > Updated NGC Summaries

Updated NGC Summaries

Use the index below to find guidelines (listed by guideline developer) that have been updated. Select "All" to see a complete list of updated NGC Guideline Summaries (organized alphabetically by guideline developer). In each case the withdrawn guideline has been replaced with a new/revised guideline. For a list of guidelines that have been permanently withdrawn from the site, go to Withdrawn NGC Summaries.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

The National Guideline Clearinghouse™ currently contains 1767 guidelines that have been superceded.

California Diabetes Program

  1. Basic guidelines for diabetes care. (NGC-3369)
    • Diabetes Coalition of California, California Diabetes Prevention and Control Program. Basic guidelines for diabetes care. Sacramento (CA): California Diabetes Prevention and Control Program, Department of Health Services; 2003. 26 p.

    CURRENT NGC SUMMARY: Basic guidelines for diabetes care. (NGC-4591)

Canadian Task Force on Preventive Health Care

  1. Breast feeding. (NGC-1254)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Breast feeding. p. 232-42. [33 references]

    CURRENT NGC SUMMARY: Interventions to promote breast-feeding: applying the evidence in clinical practice. (NGC-3651)

  2. Screening for diabetes mellitus in the non-pregnant adult. (NGC-1282)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for diabetes mellitus in the non-pregnant adult. p. 602-9. [19 references]

    CURRENT NGC SUMMARY: Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care. (NGC-4089)

Centers for Disease Control and Prevention

  1. (1) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children.
    (2) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. (NGC-0060)
    • Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. MMWR Recomm Rep 1997 Mar 28;46(RR-7):1-25. [50 references]


    • Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2000 Nov 17;49(RR13):1-8. [17 references]

    CURRENT NGC SUMMARY: (1) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children.
    (2) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. (Addendum)     (NGC-3288)

  2. (1) Prevention and treatment of tuberculosis among patients with infected human immunodeficiency virus: Principles of therapy and revised recommendations.
    (2) Notice to readers: updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    (3) Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patient (NGC-3404)
    • Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2004 Jan 20. 6 p. [30 references]


    • Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. MMWR Recomm Rep 1998 Oct 30;47(RR-20):1-58. [162 references] PubMed


    • Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitor. MMWR Morb Mortal Wkly Rep 2000 Mar 10;49(9):185-9. [10 references] PubMed

    CURRENT NGC SUMMARY: Managing drug interactions in the treatment of HIV-related tuberculosis. (NGC-6326)

  3. (1) Targeted tuberculin testing and treatment of latent tuberculosis infection.
    (2) Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations - United States, 2001. (NGC-1528)
    • Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000 Jun;49(RR-6):1-54. [169 references]


    • Update: fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States 2001. MMWR Recomm Rep 2001 Aug 31;50(34):733-5.

    CURRENT NGC SUMMARY: (1) Targeted tuberculin testing and treatment of latent tuberculosis infection.
    (2) Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
    (3) Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.     (NGC-3134)

  4. Cervical cancer screening for women who attend STD clinics or have a history of STDs. Sexually transmitted diseases treatment guidelines 2002. (NGC-2467)
    • Centers for Disease Control and Prevention. Cervical cancer screening for women who attend STD clinics or have a history of STDs. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):57-9.

    CURRENT NGC SUMMARY: Cervical cancer screening for women who attend STD clinics or have a history of STDs. Sexually transmitted diseases treatment guidelines 2006. (NGC-5192)

  5. Clinical prevention guidelines. Sexually transmitted diseases treatment guidelines 2002. (NGC-2456)
    • Centers for Disease Control and Prevention. Clinical prevention guidelines. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):2-5.

    CURRENT NGC SUMMARY: Clinical prevention guidance. Sexually transmitted diseases treatment guidelines 2006. (NGC-5181)

  6. Congenital syphilis. Sexually transmitted diseases treatment guidelines 2002. (NGC-2460)
    • Centers for Disease Control and Prevention. Congenital syphilis. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):26-8.

    CURRENT NGC SUMMARY: Congenital syphilis. Sexually transmitted diseases treatment guidelines 2006. (NGC-5185)

  7. Diagnosis and management of foodborne illnesses: a primer for physicians. (NGC-1933)
    • Diagnosis and management of foodborne illnesses: a primer for physicians. MMWR Recomm Rep 2001 Jan 26;50 (RR-2):1-69. [95 references]

    CURRENT NGC SUMMARY: Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. (NGC-3593)

  8. Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines 2002. (NGC-2459)
    • Centers for Disease Control and Prevention. Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):11-25.

    CURRENT NGC SUMMARY: Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines 2006. (NGC-5184)

  9. Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. (NGC-5187)
    • Centers for Disease Control and Prevention, Workowski KA, Berman SM. Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006 [published errata appear in MMWR Morb Mortal Wkly Rep 2006 Sep 15;55(36):997]. MMWR Morb Mortal Wkly Rep 2006 Aug 4;55(RR-11):35-49. [222 references]

    CURRENT NGC SUMMARY: (1) Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. (2) Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. (NGC-5597)

  10. Diseases characterized by vaginal discharge. Sexually transmitted diseases treatment guidelines 2002. (NGC-2463)
    • Centers for Disease Control and Prevention. Diseases characterized by vaginal discharge. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):42-8.

    CURRENT NGC SUMMARY: Diseases characterized by vaginal discharge. Sexually transmitted diseases treatment guidelines 2006. (NGC-5188)

  11. Ectoparasitic infections. Sexually transmitted diseases treatment guidelines 2002. (NGC-2471)
    • Centers for Disease Control and Prevention. Ectoparasitic infections. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):67-9.

    CURRENT NGC SUMMARY: Ectoparasitic infections. Sexually transmitted diseases treatment guidelines 2006. (NGC-5196)

  12. Epidemic/epizootic West Nile virus in the United States: Revised guidelines for surveillance, prevention, and control. (NGC-2011)
    • Epidemic/epizootic West Nile Virus in the United States: revised guidelines for surveillance, prevention, and control. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2001 Apr. 104 p. [55 references]

    CURRENT NGC SUMMARY: Epidemic/epizootic West Nile virus in the United States: guidelines for surveillance, prevention, and control. (NGC-3165)

  13. Epididymitis. Sexually transmitted diseases treatment guidelines 2002. (NGC-2465)
    • Centers for Disease Control and Prevention. Epididymitis. Sexually transmitted Diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):52-3.

    CURRENT NGC SUMMARY: Epididymitis. Sexually transmitted diseases treatment guidelines 2006. (NGC-5190)

  14. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-5379)
    • Kroger AT, Atkinson WL, Marcuse EK, Pickering LK, Advisory Committee on Immunization Practices (ACIP) Centers for Disease. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published errata appear in MMWR Morb Mortal Wkly Rep 2007 Mar 23;56(11):256]. MMWR Recomm Rep 2006 Dec 1;55(RR-15):1-48. [202 references] PubMed

    CURRENT NGC SUMMARY: 1) General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). 2) Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. (NGC-6390)

  15. Guidelines for isolation precautions in hospitals. (NGC-0842)
    • Centers for Disease Control and Prevention (CDC), Hospital Infection Control Practices Advisory Committee. Guidelines for isolation precautions in hospital infection control advisory committee. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 1996 Jan 1. 38 p. (CDC prevention guidelines; no. 1/96). [97 references]

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Administrative responsibilities. (NGC-5763)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Education and training. (NGC-5764)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Surveillance. (NGC-5765)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Standard precautions. (NGC-5766)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Transmission-based precautions. (NGC-5767)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Protective environment. (NGC-5768)

  16. Guidelines for prevention of nosocomial pneumonia. (NGC-0841)
    • Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Recomm Rep 1997 Jan 3;46(RR-1):1-79. [140 references] PubMed

    CURRENT NGC SUMMARY: Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. (NGC-3506)

  17. Guidelines for the use of antiretroviral agents in pediatric HIV infection. (NGC-6332)
    • Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Bethesda (MD): U.S. Department of Health and Human Services; 2008 Feb 28. 134 p. [359 references]

    CURRENT NGC SUMMARY: Guidelines for the use of antiretroviral agents in pediatric HIV infection. (NGC-6652)

  18. Guidelines for using the QuantiFERON®-TB test for diagnosing latent mycobacterium tuberculosis infection. (NGC-2844)
    • Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 Jan 31;52(RR-2):15-8. [6 references] PubMed

    CURRENT NGC SUMMARY: Guidelines for using the QuantiFERON®-TB gold test for detecting mycobacterium tuberculosis infection, United States. (NGC-4741)

  19. Hepatitis C. Sexually transmitted diseases treatment guidelines 2002. (NGC-2469)
    • Centers for Disease Control and Prevention. Hepatitis C. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):64-6.

    CURRENT NGC SUMMARY: Hepatitis C. Sexually transmitted diseases treatment guidelines 2006. (NGC-5194)

  20. HIV infection: detection, counseling, and referral. Sexually transmitted diseases treatment guidelines 2002. (NGC-2458)
    • Centers for Disease Control and Prevention. HIV infection: detection, counseling, and referral. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):7-11.

    CURRENT NGC SUMMARY: HIV infection: detection, counseling, and referral. Sexually transmitted diseases treatment guidelines 2006. (NGC-5183)

  21. Human papillomavirus infection. Sexually transmitted diseases treatment guidelines 2002. (NGC-2466)
    • Centers for Disease Control and Prevention. Human papillomavirus infection. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):53-7.

    CURRENT NGC SUMMARY: HPV infection and genital warts. Sexually transmitted diseases treatment guidelines 2006. (NGC-5191)

  22. Management of patients who have a history of penicillin allergy. Sexually transmitted diseases treatment guidelines 2002. (NGC-2461)
    • Centers for Disease Control and Prevention. Management of patients who have a history of penicillin allergy. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):28-30.

    CURRENT NGC SUMMARY: Management of patients who have a history of penicillin allergy. Sexually transmitted diseases treatment guidelines 2006. (NGC-5186)

  23. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. (NGC-0906)
    • Centers for Disease Control and Prevention (CDC). Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998 Sep 25;47(RR-17):1-14. [56 references] PubMed

    CURRENT NGC SUMMARY: Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. (NGC-4049)

  24. Pelvic inflammatory disease. Sexually transmitted diseases treatment guidelines 2002. (NGC-2464)
    • Centers for Disease Control and Prevention. Pelvic inflammatory disease. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):48-52.

    CURRENT NGC SUMMARY: Pelvic inflammatory disease. Sexually transmitted diseases treatment guidelines 2006. (NGC-5189)

  25. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-1794)
    • Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. MMWR Recomm Rep 2000 Oct 6;49(RR-9):1-38. [123 references]

    CURRENT NGC SUMMARY: (1) Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2) Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24--59 months who are not completely vaccinated. (NGC-6419)

  26. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. (NGC-5730)
    • Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ, Advisory Committee on Immunization Practices (ACIP), Centers for Disease. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007 Jul 13;56(RR-6):1-54. PubMed

    CURRENT NGC SUMMARY: Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. (NGC-6678)

  27. Prevention and control of tuberculosis in correctional facilities: recommendations of the Advisory Council for the Elimination of Tuberculosis. (NGC-0102)
    • Centers for Disease Control and Prevention, Advisory Council for the Elimination of Tuberculosis. Prevention and control of tuberculosis in correctional facilities. MMWR Recomm Rep 1997 Jun 7;45(RR-8):1-27. [49 references]

    CURRENT NGC SUMMARY: Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. (NGC-5076)

  28. Prevention of Hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-1365)
    • Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999 Oct 1;48(RR-12):1-37. [161 references]

    CURRENT NGC SUMMARY: Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-5008)

  29. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-5727)
    • Marin M, Guris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007 Jun 22;56(RR-4):1-40. [204 references] PubMed

    CURRENT NGC SUMMARY: 1) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). 2) Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. (NGC-6391)

  30. Proctitis, proctocolitis, and enteritis. Sexually transmitted diseases treatment guidelines 2002. (NGC-2470)
    • Centers for Disease Control and Prevention. Proctitis, proctocolitis, and enteritis. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):66-7.

    CURRENT NGC SUMMARY: Proctitis, proctocolitis, and enteritis. Sexually transmitted diseases treatment guidelines 2006. (NGC-5195)

  31. Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Version 2. Supplement E: managing international travel-related transmission risk. (NGC-3380)
    • Centers for Disease Control and Prevention (CDC). Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Version 2. Supplement E: managing international travel-related transmission risk. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2003 Dec 29. 14 p.

    CURRENT NGC SUMMARY: Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Version 3. Supplement E: managing international travel-related transmission risk. (NGC-4176)

  32. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. (NGC-6030)
    • Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Rockville (MD): U.S. Public Health Service; 2007 Nov 2. 96 p. [315 references]

    CURRENT NGC SUMMARY: Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. (NGC-6627)

  33. Revised guidelines for HIV counseling, testing, and referral. (NGC-2278)
    • Centers for Disease Control and Prevention (CDC). Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001 Nov 9;50(RR-19):1-58. [151 references] PubMed

    CURRENT NGC SUMMARY: Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. (NGC-5246)

  34. Revised recommendations for HIV screening of pregnant women. (NGC-2279)
    • Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep 2001 Nov 9;50(RR-19):59-86. [87 references] PubMed

    CURRENT NGC SUMMARY: Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. (NGC-5246)

  35. Sexual assault and STDs. Sexually transmitted diseases treatment guidelines 2002. (NGC-2472)
    • Centers for Disease Control and Prevention. Sexual assault and STDs. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):69-74.

    CURRENT NGC SUMMARY: Sexual assault and STDs. Sexually transmitted diseases treatment guidelines 2006. (NGC-5197)

  36. Special populations. Sexually transmitted diseases treatment guidelines 2002. (NGC-2457)
    • Centers for Disease Control and Prevention. Special populations. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):5-7.

    CURRENT NGC SUMMARY: Special populations. Sexually transmitted diseases treatment guidelines 2006. (NGC-5182)

  37. Vaccine preventable STDs. Sexually transmitted diseases treatment guidelines 2002. (NGC-2468)
    • Centers for Disease Control and Prevention. Vaccine preventable STDs. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):59-64.

    CURRENT NGC SUMMARY: Vaccine preventable STDs. Sexually transmitted diseases treatment guidelines 2006. (NGC-5193)

Cincinnati Children's Hospital Medical Center

  1. Evidence based clinical care guideline for acute gastroenteritis (AGE) in children aged 2 months through 5 years. (NGC-4664)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical care guideline for acute gastroenteritis (AGE) in children aged 2 months through 5 years. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Oct 31. 15 p. [50 references]

    CURRENT NGC SUMMARY: Evidence-based clinical care guideline for acute gastroenteritis (AGE) in children aged 2 months through 5 years. (NGC-5079)

  2. Evidence based clinical practice guideline for anesthesia, analgesia and sedation following arterial switch operation. (NGC-3172)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for anesthesia, analgesia and sedation following arterial switch operation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jan 22. 8 p. [14 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for anesthesia, analgesia and sedation following arterial switch operation. (NGC-5289)

  3. Evidence based clinical practice guideline for children with acute bacterial sinusitis in children 1 to 18 years of age. (NGC-2344)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for children with acute bacterial sinusitis in children 1 to 18 years of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Apr 27. 17 p. [234 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for management of acute bacterial sinusitis in children 1 to 18 years of age. (NGC-5080)

  4. Evidence based clinical practice guideline for children with hypertrophic pyloric stenosis. (NGC-2345)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for hypertrophic pyloric stenosis. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Aug 8. 16 p. [186 references]

    CURRENT NGC SUMMARY: Evidence based clinical practice guideline hypertrophic pyloric stenosis. (NGC-6224)

  5. Evidence based clinical practice guideline for cytomegalovirus prophylaxis following solid organ, blood and marrow transplants. (NGC-3170)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for cytomegalovirus prophylaxis following solid organ, blood and marrow transplants. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jun 7. 16 p. [145 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for cytomegalovirus prophylaxis following solid organ transplants. (NGC-6205)

  6. Evidence based clinical practice guideline for inotropic support with phosphodiesterase inhibitors after repair of tetralogy of Fallot. (NGC-3649)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for inotropic support with phosphodiesterase inhibitors after repair of tetralogy of Fallot. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jan 25. 9 p. [16 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for inotropic support with phosphodiesterase inhibitors after repair of tetralogy of Fallot. (NGC-5205)

  7. Evidence based clinical practice guideline for medical management of bronchiolitis in infants less than 1 year of age presenting with a first time episode. (NGC-4464)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of bronchiolitis in infants less than 1 year of age presenting with a first time episode. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Aug 15. 12 p. [85 references]

    CURRENT NGC SUMMARY: Evidence-based clinical practice guideline for medical management of bronchiolitis in infants less than 1 year of age presenting with a first time episode. (NGC-5078)

  8. Evidence based clinical practice guideline for medical management of first time acute urinary tract infection in children 12 years of age or less. (NGC-4334)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of first time acute urinary tract infection in children 12 years of age or less. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Apr 18. 20 p. [61 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for medical management of first urinary tract infection in children 12 years of age or less. (NGC-5348)

  9. Evidence based clinical practice guideline for medical management of otitis media in children 2 months to 6 years of age. (NGC-1198)
    • Cincinnati Children's Hospital Medical Center. Evidence-based clinical practice guideline for medical management of otitis media in children 2 months to 6 years of age. Cincinnati (OH): Children's Hospital Medical Center (CHMC); 1999. 8 p.

    CURRENT NGC SUMMARY: Evidence based clinical practice guideline for medical management of otitis media with effusion in children 2 months to 13 years of age. (NGC-3957)

    CURRENT NGC SUMMARY: Evidence based clinical practice guideline for medical management of acute otitis media in children 2 months to 13 years of age. (NGC-3958)

  10. Evidence based clinical practice guideline for prevention of thromboembolism after cavopulmonary anastomosis (bidirectional Glenn and Fontan operations). (NGC-3171)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for prevention of thromboembolism after cavopulmonary anastomosis (bidirectional Glenn and Fontan operations). Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 May 29. 10 p. [20 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for prevention of thromboembolism after cavopulmonary anastamosis (bidirectional Glenn and Fontan operations). (NGC-5291)

  11. Evidence based clinical practice guideline of fever of uncertain source. Outpatient evaluation and management for children 2 months to 36 months of age. (NGC-1879)
    • Cincinnati Children's Hospital Medical Center. Evidence-based clinical practice guideline of fever of uncertain source. Outpatient evaluation and management for children 2 months to 36 months of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2000. 10 p. [36 references]

    CURRENT NGC SUMMARY: Evidence based clinical practice guideline for fever of uncertain source in children 2 to 36 months of age. (NGC-3783)

  12. Evidence based clinical protocol guideline for fever of uncertain source in infants 60 days of age or less. (NGC-0659)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical protocol guideline for fever of uncertain source in infants 60 days of age or less. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 1998. 32 p. [51 references]

    CURRENT NGC SUMMARY: Evidence based clinical practice guideline for fever of uncertain source in infants 60 days of age or less. (NGC-3166)

  13. Evidence-based care guideline for community acquired pneumonia in children 60 days through 17 years of age. (NGC-4743)
    • Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for community acquired pneumonia in children 60 days through 17 years of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Dec. 16 p. [80 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for community acquired pneumonia in children 60 days through 17 years of age. (NGC-5199)

  14. Evidence-based care guideline for inotropic support with phosphodiesterase inhibitors after arterial switch operation. (NGC-5038)
    • Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for inotropic support with phosphodiesterase inhibitors after arterial switch operation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2006 Jan 10. 8 p. [16 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for inotropic support with phosphodiesterase inhibitors after arterial switch operation. (NGC-5211)

  15. Evidence-based care guideline for necrotizing enterocolitis (NEC) among very low birth weight infants. (NGC-4466)
    • Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for necrotizing enterocolitis (NEC) among very low birth weight infants. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Jul 14. 12 p. [91 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for necrotizing enterocolitis (NEC) among very low birth weight infants. (NGC-5522)

Consortium for Spinal Cord Medicine

  1. Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health-care facilities. (NGC-0396)
    • Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health-care facilities. J Spinal Cord Med 1997 Jul;20(3):284-308. [88 references]

    CURRENT NGC SUMMARY: Acute management of autonomic dysreflexia: individuals with spinal cord injury presenting to health-care facilities. (NGC-2190)

  2. Prevention of thromboembolism in spinal cord injury. (NGC-0395)
    • Prevention of thromboembolism in spinal cord injury. J Spinal Cord Med 1997 Jul;20(3):259-83. [60 references]

    CURRENT NGC SUMMARY: Prevention of thromboembolism in spinal cord injury. (NGC-2191)

Council on Chiropractic Practice

  1. Vertebral subluxation in chiropractic practice. (NGC-0677)
    • Council on Chiropractic Practice. Vertebral subluxation in chiropractic practice. Chandler (AZ): Council on Chiropractic Practice; 1998. 120 p. (Clinical practice guideline; no. 1). [939 references]

    CURRENT NGC SUMMARY: Vertebral subluxation in chiropractic practice. (NGC-3438)


Search Help
Detailed Search
Frequent Searches

What's New

» What's New This Week
» What's New Archive
» Guideline Index
» Guidelines In Progress
» Guideline Archive
» Manage Subscriptions